Acomplia, Zimulti Diet Pills  
Slimmingalert (Acomplia)About SlimmingAlert (Acomplia)Acomplia (Zimulti) InformationAcomplia Clinical StudyAcomplia Zimulti NewsBuy Acomplia Zimulti
Acomplia
Acomplia (Rimonabant) News

Replicas of Diet Drug Acomplia Extensively Swopped At Indian Pharmacies

While the generic versions of acomplia can be sold legally in India, together with the fact that pharmaceutical companies can lawfully produce generic equivalents of those medicines which are patented before 1995, the sale of these Indian equivalents is not permitted in the U.S., Canada and Europe.........More

Aug 16, 2007

Sanofi hopes to Receive New Data for Acomplia by the end......

The French pharmaceutical giant Sanofi-Aventis anticipates to have new clinical data for its revolutionary diet drug by the end of 2008 to 2010, which in turn, may strengthen its prospects of attaining the FDA approval to sale anti-obesity drug Acomplia in the United States under the new brand name "Zimulti".
"We are expecting outcomes from the continuing studies in diabetes by the end of 2008 or at the beginning of 2009, but the long-run findings from the Crescendo study would come out in 2010" declared Pharmaceuticals head Hanspeter Spek.........More

Aug 7, 2007

 
More News »
 

Sign up for free Newsletter for Special Offers & News for Acomplia.

Acomplia (Zimulti)

If obesity is a threat to your health and well-being; then weight loss is a priority. Obesity is not just being overweight. Obesity is assessed by the BMI count i.e. Body Mass Index. If the BMI count exceeds 30, then the patient is clinically diagnosed with obesity. Obesity can cause many related diseases like hypertension, high cholesterol, diabetes, etc. Another vice that can take a toll on your health is smoking. Smoking has been the most threatening factor for causing respiratory problems and fatal illness like cancer.

Acomplia Weight Loss Diet Pills
PRODUCT
QUANTITY
PRICE(£)
ORDER
Acomplia 20 MG
28
£128
Acomplia 20 MG
56
£245
Acomplia 20 MG
84
£362

As a large population of the world is affected by obesity and smoking, the French pharmaceutical giant Sanofi-Aventis has introduced a revolutionary drug Acomplia (Rimonabant) or Zimulti which works as a diet pill as well as a smoking cessation drug.

Zimulti (Rimonabant), which works with the help of the active ingredient Rimonabant (Acomplia), initiates weight loss by blocking the CB-1 receptors found in the Endo-cannabinoid (EC) system. Zimulti (Acomplia) works by targeting these receptors, thereby, regulating your appetite and managing hunger pangs. Zimulti (Rimonabant) when used in conjunction with balanced diet, regular exercise and behavior alteration can prove to be an exemplary drug for weight loss with additional benefits of smoking cessation.

Zimulti (Acomplia) is strictly recommended to be used under prescription and in consultation with your doctor so as to ward off side effects and possible drug interactions. This diet pill should not be used by pregnant women and lactating mothers. Moreover, Zimulti should be strictly kept away from the reach of children.

Acomplia

Revolutionary weight loss drug acomplia (Rimonabant) still has to make a lot of efforts to prove its mettle for sale in the untied states as the U.S. Food and drug administration panel clearly voted out the odds of drug being marketed as Zimulti in the United States on June 13th. In an unambiguous decision, the FDA's advisory panel finally rebuffed the French drug maker Sanofi-Aventis's appeal to approve its diet pills to be sold under the new name "Zimulti" in the U.S. citing safety concerns. Based on the data provided by the maker for review last year, the FDA's advisory panel aired a number of concerns over the safety of acomplia diet pills, particularity about its effects on one's psychological well-being.

In addition to available data on the safety of the weight loss drug, the panel also considered reports pertaining to the adverse effects of acomplia as to make an impartial decision.

Zimulti/Acomplia Treatment

Put an end to obesity with Zimulti treatment. Zimulti is an intended name for Rimonabant for its launch in the US. It is basically an anti-obesity drug.

It can give respite to people those who have a BMI (Body Mass Index) greater than 30. BMI is a calculated value of your height in proportion to your weight. A high BMI level, increases your chances to be prone to health related issues like high blood pressure, type 2 diabetes, heart attack amongst others.

Zimulti drug causes weight reduction, a customary dosage of Zimulti is considered similar to that of Acomplia dosage which is 20mg. It is to be swallowed in one gulp with a full glass of water. This pill is to be consumed in conjunction with a low-calorie diet and regular exercises.

Do not overdose. Incase, you miss a dosage take it as soon as you remember. If it is time for your next dosage, then continue with your scheduled dosage. Prior consultation with your doctor is recommended before embarking upon Zimulti treatment.

Pregnant women and breast-feeding mothers should avoid the consumption of Zimulti diet drug. Your doctor should also be made aware of your medical history or any medication you were or are engaged in, to avoid contraindication of Zimulti (Acomplia) treatment.

Rimonabant (Acomplia) is available for purchase by prescription in Europe under the name acomplia.

   
Contact Us | Disclaimer | Terms & Conditions

Copyright ©2007, SlimmingAlert.com. All rights reserved.